EHC
Income statement / Annual
Last year (2023), Encompass Health Corporation's total revenue was $4.80 B,
an increase of 10.41% from the previous year.
In 2023, Encompass Health Corporation's net income was $352.00 M.
See Encompass Health Corporation’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$4.80 B
|
$4.35 B
|
$5.12 B
|
$4.64 B
|
$4.61 B
|
$4.28 B
|
$3.92 B
|
$3.65 B
|
$3.12 B
|
$2.37 B
|
| Cost of Revenue |
$3.87 B |
$202.10 M |
$209.30 M |
$200.50 M |
$167.90 M |
$158.70 M |
$149.30 M |
$140.00 M |
$128.70 M |
$111.90 M |
| Gross Profit |
$933.50 M |
$4.15 B |
$4.91 B |
$4.44 B |
$4.44 B |
$4.12 B |
$3.77 B |
$3.51 B |
$2.99 B |
$2.26 B |
| Gross Profit Ratio |
0.19 |
0.95 |
0.96 |
0.96 |
0.96 |
0.96 |
0.96 |
0.96 |
0.96 |
0.95 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$201.70 M
|
$2.60 B
|
$3.16 B
|
$2.92 B
|
$2.90 B
|
$2.65 B
|
$2.40 B
|
$2.19 B
|
$1.86 B
|
$1.34 B
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$201.70 M
|
$2.60 B
|
$3.16 B
|
$2.92 B
|
$2.90 B
|
$2.65 B
|
$2.40 B
|
$2.19 B
|
$1.86 B
|
$1.34 B
|
| Other Expenses |
$0.00 |
$914.00 M |
$941.80 M |
$877.40 M |
$842.30 M |
$2.20 M |
$4.10 M |
$2.90 M |
$5.50 M |
$31.20 M |
| Operating Expenses |
$693.90 M |
$3.52 B |
$4.11 B |
$3.80 B |
$3.74 B |
$3.44 B |
$3.12 B |
$2.86 B |
$2.43 B |
$1.80 B |
| Cost And Expenses |
$4.07 B |
$3.72 B |
$4.32 B |
$4.00 B |
$3.91 B |
$3.60 B |
$3.27 B |
$3.00 B |
$2.56 B |
$1.91 B |
| Interest Income |
$0.00 |
$175.70 M |
$164.30 M |
$183.70 M |
$159.70 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$143.50 M |
$175.70 M |
$164.60 M |
$184.20 M |
$159.70 M |
$147.30 M |
$154.40 M |
$172.10 M |
$142.90 M |
$109.20 M |
| Depreciation &
Amortization |
$273.90 M
|
$243.60 M
|
$219.60 M
|
$243.00 M
|
$218.70 M
|
$199.70 M
|
$183.80 M
|
$172.60 M
|
$139.70 M
|
$107.70 M
|
| EBITDA |
$1.01 B
|
$873.80 M
|
$879.00 M
|
$815.20 M
|
$911.20 M
|
$881.30 M
|
$833.20 M
|
$823.80 M
|
$709.20 M
|
$592.00 M
|
| EBITDA Ratio |
0.21 |
0.2 |
0.21 |
0.19 |
0.21 |
0.21 |
0.22 |
0.23 |
0.23 |
0.26 |
| Operating Income Ratio
|
0.15
|
0.14
|
0.16
|
0.14
|
0.16
|
0.16
|
0.17
|
0.18
|
0.18
|
0.2
|
| Total Other
Income/Expenses Net |
-$124.60 M
|
-$1.09 B
|
-$969.90 M
|
$103.80 M
|
-$130.20 M
|
-$188.40 M
|
-$153.00 M
|
-$166.80 M
|
-$158.60 M
|
-$78.80 M
|
| Income Before Tax |
$607.20 M |
$450.80 M |
$657.20 M |
$472.60 M |
$562.30 M |
$493.20 M |
$496.40 M |
$482.00 M |
$395.60 M |
$386.90 M |
| Income Before Tax Ratio
|
0.13
|
0.1
|
0.13
|
0.1
|
0.12
|
0.12
|
0.13
|
0.13
|
0.13
|
0.16
|
| Income Tax Expense |
$132.20 M |
$100.10 M |
$139.60 M |
$103.80 M |
$115.90 M |
$118.90 M |
$160.60 M |
$163.90 M |
$141.90 M |
$110.70 M |
| Net Income |
$352.00 M |
$271.00 M |
$412.20 M |
$284.20 M |
$358.70 M |
$292.30 M |
$256.30 M |
$247.60 M |
$183.10 M |
$222.00 M |
| Net Income Ratio |
0.07 |
0.06 |
0.08 |
0.06 |
0.08 |
0.07 |
0.07 |
0.07 |
0.06 |
0.09 |
| EPS |
3.54 |
2.72 |
4.15 |
2.87 |
3.65 |
2.99 |
2.73 |
2.77 |
2.02 |
2.46 |
| EPS Diluted |
3.47 |
2.7 |
4.11 |
2.85 |
3.61 |
2.93 |
2.69 |
2.59 |
1.91 |
2.29 |
| Weighted Average Shares
Out |
$99.50 M
|
$99.20 M
|
$99.00 M
|
$98.60 M
|
$98.00 M
|
$97.90 M
|
$93.70 M
|
$89.10 M
|
$89.40 M
|
$86.80 M
|
| Weighted Average Shares
Out Diluted |
$101.30 M
|
$100.40 M
|
$100.20 M
|
$99.80 M
|
$99.40 M
|
$99.80 M
|
$99.30 M
|
$99.50 M
|
$101.00 M
|
$100.70 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
